Drug Approval | June 27, 2024
Shilpa Medicare Bio Analytical unit gets "No Action Indicated" classification from USFDA
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
The funds raised from the Whitathon run are utilized to treat underprivileged children suffering from Retinoblastoma
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
10th edition of the event is scheduled to be held during May 30-June 1 at Hitex, Hyderabad
Thermo Fisher has equipped this Centre for Innovation with state-of-the-art platforms such as CellInsight CX7 LZR Pro High Content Screening Platform
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Subscribe To Our Newsletter & Stay Updated
